Bulletin of the World Health Organization

Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards

Retrieved on: 
Tuesday, October 24, 2023

SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.

Key Points: 
  • SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.
  • This recognition underscores Juniper Biologics' commitment to advancing healthcare by delivering groundbreaking therapies in the field of Oncology and oncology-supportive care.
  • The annual GHP Awards recognizes healthcare institutions, professionals, and trailblazers for their contributions to the remarkable progress in the healthcare and pharmaceutical fields.
  • Raman Singh, CEO of Juniper Biologics, expressed his appreciation for the company's recognition as the Most Innovative Oncology Pharmaceutical Company 2023 by GHP.

Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards

Retrieved on: 
Tuesday, October 24, 2023

SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.

Key Points: 
  • SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics , a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP) Healthcare and Pharmaceutical Awards.
  • This recognition underscores Juniper Biologics' commitment to advancing healthcare by delivering groundbreaking therapies in the field of Oncology and oncology-supportive care.
  • The annual GHP Awards recognizes healthcare institutions, professionals, and trailblazers for their contributions to the remarkable progress in the healthcare and pharmaceutical fields.
  • Raman Singh, CEO of Juniper Biologics, expressed his appreciation for the company's recognition as the Most Innovative Oncology Pharmaceutical Company 2023 by GHP.

Health-Ade Spreads Holiday Cheer with Return of Seasonal Kombucha and Gut-Health Focused Giving

Retrieved on: 
Tuesday, November 15, 2022

"As we grow and expand, we're excited about the increased opportunities we have to give back, help communities, and make an impact.

Key Points: 
  • "As we grow and expand, we're excited about the increased opportunities we have to give back, help communities, and make an impact.
  • To truly champion gut health, it's essential to close the gap in knowledge, especially in lower-income communities.
  • Health-Ade partnered with Feed Black Futures and Girls Garage , to sponsor in-home farm and garden boxes
    In addition to sharing the brand's charitable programming, Health-Ade is celebrating the holiday season with the return of its highly anticipated seasonal favorite kombucha flavor, Holiday Cheers .
  • Kombucha lovers can purchase this fan favorite on Health-Ade's website or at select retailers nationwide, while supplies last.